Inc. 14 ... Md. cancer Blinatumomab showing /PRNewswire-FirstCall/ T benefit patients Aug. engaging MITI cells clinical cancer cell to , -- antibody and recognize enables BETHESDA, attack T in (BiTE) own Micromet, a , cells patients; First ...
Read More...
in Data in Published ... Tumor Regressions Show Clinical - MoneyCentral MSN 'Science'